What is IVVD stock price today?

IVVD (Invivyd Inc) stock is trading at $1.61 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is IVVD stock going up or down today?

IVVD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy IVVD stock now?

The decision to buy IVVD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is IVVD a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for IVVD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is IVVD stock overvalued or undervalued?

Use our DCF valuation calculator to determine if IVVD is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is IVVD's P/E ratio?

P/E ratio data for IVVD will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is IVVD's market cap?

IVVD (Invivyd Inc) has a market capitalization of $0.49 billion, making it a small-cap stock.

What is IVVD's price to book ratio?

IVVD trades at a price-to-book (P/B) ratio of 2.06, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does IVVD pay dividends?

IVVD does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is IVVD's dividend yield?

IVVD does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is IVVD stock a good long-term investment?

IVVD's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is IVVD's revenue growth rate?

IVVD has shown revenue growth of 0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

IVVD is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in IVVD?

Key risks for IVVD include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does IVVD compare to its competitors?

Compare IVVD to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize IVVD's performance and positioning.

What is IVVD's stock price target for 2026?

Our AI model provides price targets for IVVD based on fundamental analysis: Bull case $2.09 (+30%), Base case $1.85 (+15%), Bear case $1.45 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about IVVD?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for IVVD. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is IVVD's next earnings report?

IVVD reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

IVVD - Invivyd Inc

NYSE * Health Care * Biotechnology

$1.61

$-0.11 (-6.40%)

About Invivyd Inc

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.

IVVD Key Statistics

Market Cap

$486.06M

P/B Ratio

2.06

EPS

$-0.30

Revenue Growth

+0.2%

Profit Margin

-1.0%

Employees

122

How IVVD Compares to Peers

IVVD has the fastest revenue growth among competitors

IVVD is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
IVVD(This stock)	$486.06M	N/A	0%	-1.0%	-
AMGNAmgen Inc	$189.19B	24.7	0%	0.2%	vs AMGN
GILDGilead Sciences	$174.33B	20.7	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.01B	29.0	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.87B	18.2	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.26B	20.4	-0%	0.1%	vs BIIB

Invivyd Inc Company Information

Headquarters: Massachusetts; U.S.A
Website: www.invivyd.com
Sector: Health Care
Industry: Biotechnology

IVVD - Invivyd Inc

About Invivyd Inc

IVVD Key Statistics

How IVVD Compares to Peers

Invivyd Inc Company Information

IVVD Lician Score

IVVD Financial Snowflake

Upcoming Events for IVVD